Xenothera SAS
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Polyspecific Antibodies in Lymphoproliferative T-cell Disorders (NCT06495723) | Xenothera SAS | 2024-07-09 |
| FIH XON7 in Advanced/Metastatic Solid Tumors (NCT06154291) | Xenothera SAS | 2023-11-14 |
| A First-in-Human Study With XAB05 in Healthy Subjects (NCT05307406) | Xenothera SAS | 2022-01-24 |
| Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19 (NCT04928430) | Xenothera SAS | 2021-04-28 |
| First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients (NCT04431219) | Xenothera SAS | 2019-11-26 |
Track Xenothera SAS automatically
Every clearance here is in the API, with alerts when new ones post.